AR

🔍 What is AR?

The AR gene encodes the androgen receptor, a nuclear hormone receptor that binds androgens (e.g., testosterone and dihydrotestosterone). AR acts as a transcription factor regulating genes involved in male sexual development and maintenance.


📊 Prevalence of AR Alterations in Cancer

Cancer TypeAR Alterations Prevalence
Prostate cancerNearly all advanced prostate cancers show AR alterations (amplification, mutations, splice variants)
Breast cancer~10-15% (especially in some triple-negative subtypes)
Other cancersRare but occasionally seen in other hormone-sensitive tumors

⚙️ Mechanism of Oncogenic Activation

  • AR amplification and overexpression: Increase sensitivity to low androgen levels, driving prostate cancer progression.
  • Point mutations in AR can alter ligand specificity or confer resistance to anti-androgen therapies.
  • Splice variants lacking the ligand-binding domain can result in constitutive, ligand-independent activity.
  • Activated AR promotes transcription of genes driving proliferation and survival in hormone-dependent tumors.

💊 Targeted Therapies

Please log in to use or view. If you do not have an account, please register.

Leave a Reply